TOPIC 356: FLUOROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
Award amount
$1,480,983Program and phase
SBIR · Phase IIAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LUCERNA INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- J3MWGA6WFCG3
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- In vivo imaging platform for DM1 drug discovery
- Targeted RNA degradation assay for new antiviral drug discovery
- Cell-based RNA degradation assay for C9ALS/FTD drug discovery
- Fluorescent IRE sensor for synucleinopathy drug discovery
- Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery
Research funding history
22 SBIR/STTR records share this UEI (2011–2025). Reported award amounts total $10,266,039. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation